Collaboration with a pharma company

29 February 2016

Collaboration with a pharma company

In February 2016 Malcisbo has started an R&D collaboration with a pharma company targeting our Campylobacter vaccine. The agreement warrants the company an exclusive option on our technology and allows us to further develop our vaccine.

 

Latest News

  • 25 January 2017

    Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2017)

  • 21 December 2016

    Malcisbo participates in a CTI-funded research project on the development of a vaccine against APP.

  • 29 February 2016

    Collaboration with a pharma company

    R&D collaboration with a pharma company targeting our Campylobacter vaccine.